San Diego’s Regulus Therapeutics Readies for IPO This Week
Summary
San Diego’s Regulus Therapeutics Readies for IPO This Week Xconomy San Diego — San Diego’s Regulus Therapeutics is among eight companies on deck at the Nasdaq exchange for IPOs this week, according to a report today from Renaissance Capital, the Connecticut-based institutional research and investment management services firm.Regulus, founded five years ago, has been developing microRNA treatments for serious diseases.The company plans to list on the Nasdaq market under the symbol RGLS.At the midpoint of the proposed range, LifeLock would command a market value of $981 million.The company plans to trade its shares under the symbol LOCK.
Classifications
industries
Fintech & Banking
applications
Web and Content Management
AskAI Classifications
Labels
Content Marketing Software
SaaS
Web Analytics
Linked Companies
Shareaholic
$1M to $5M
Nasdaq, Inc.
$5M to $10M